GPR19 and neoplasm: Based on The Cancer Genome Atlas (TCGA, https://portal.Gdc.Cancer.gov), samples of 51 normal individuals and 646 tumor patients were collected for the analyses of ENHO and GPR19 gene expression (level 3 HTSeq-FPKM), immune system infiltrates, and related clinical information.